A standard infiltration of the rat tibialis anterior muscle with 0.1 ml of local anesthetics was used as a model to help choose criteria for testing the intramuscular toxicity of drugs. Anesthetics used were 0.2% carbisocaine, 1% and 2% Lidocaineg, 0.5% Marcainea, I% and 2% Mesocaineg, 1% and 2% Procaine@. Increases in the serum levels of creatine kinase were monitored for 24 hours, and the weight, as well as macro-and microscopic changes in the muscle for a period of) month. Exposure of the muscle to local anesthetics resulted in 2 types of lesions. One was characterized by selective muscle fiber damage in the injected area. The other type of lesion was a generalized one that involved a number of cell types. To assess the intramuscular toxicity of drugs we defined the type of lesion, its size, and the rate of subsequent muscle regeneration. We recommend the following criteria for the assay of myotoxicity of new drugs being developed as pharmaceutical agents: 1) serum creatine kinase level 1 hour after intramuscular injection of the drug; 2) microscopic findings at 3,7, and 21 days; 3) the cross-sectional area of the lesion at 3 days; and 4) the weight of the muscle at 7 and 21 days.
INTRODUCTION
Local damage to skeletal muscle is one of the undesirable side effects of intramuscularly (i.m.) applied drugs (9-11, 13, 17, 24, 31, 37, 38, 40, 51). Consequently, diverse methods of evaluation of lesions induced by their i.m. application have been devised for the preclinical development of drugs. These tests estimate acute muscle damage by means ofmorphological (5, 27, 29, 34, 42) and biochemical criteria (43, 4 9 , or both (14, 18), and also by in vitro methods (47) . Still, no technique is as yet in use to monitor not only acute muscle damage but also the progress of subsequent regeneration.
Studies conducted primarily on the rat have shown local anesthetics (LA) to be myotoxic substances, the intramuscular injection of which causes muscle fibers to break down and rapidly regenerate (3, 6, 15, 19, 20, 25, 32). The pathogenesis of LA myotoxicity shows impaired transport and distribution of calcium ions in the muscle fiber (7, 32). Local anesthetics have also been reported to cause mem- brane damage (23, 33) and an interference with the aminoacylation of tRNA (26) .
To develop a test for the intramuscular toxicity of drugs we used, as a model, the tibialis anterior muscle of the rat infiltrated in a single injection with a standard volume LA of diverse myotoxicity. We propose criteria for the preclinical testing of new drugs to permit the assessment of not only the extent and type of lesion but also the rate of subsequent muscle regeneration. Those criteria include estimation of serum creatine kinase (cK) activity following the i.m. application of the drug, macroscopic and microscopic examination of the drug-injected muscle, and monitoring of changes in weight. The test has already been verified in determining the intramuscular toxicity ofantiphlogistics (2 1, 38) and stomatological LA (22) .
METHODS

Experiinental Animals and Local Anesthetics
The'study was conducted on female Wistar rats of the Velaz Prague SPF breed. The initial weight of the animals was 150-200 g. Use was made of commercial solutions of local anesthetics (Table I) isocaine substance was dissolved in sterile saline solution. The control animals were injected with saline alone. All procedures and maintenance of the rats were carried out in accordance with the principles of humane treatment elaborated by the NIH.
Technique of Intramirsctilar Application
The rat, under ether narcosis, had its skin over the right tibialis anterior muscle (TA) shaved and disinfected. The injection needle (No. 5-Chirana Products Standard-0.5 mm in diameter and 27 mm in length) ofa tuberculin syringe was introduced into the longitudinal axis of the muscle belly along the anterior margin of the tibia and then slowly withdrawn while 0.1 ml LA heated to room temperature was being evenly applied. Sterilized instruments were used. To practice the application and to estimate the size of the area infiltrated, we used 1% Evans blue or 10% India ink. The use of the dyes also showed that the volume of 0.1 ml was the optimum quantity of the substance for infiltration of the TA. The average weight of this particular muscle is 330 mg in rats weighing 150-200 g. The volume of 0.05 ml would be too small (29) , while a greater amount would be disproportionate to the volume of the muscle and could easily cause damage due to pressure. Moreover, large doses might escape from the muscle, thus distorting the quantitative evaluation of the lesions.
Determination of Sertirit Creatirie Kiirase (CK) Activity
Blood samples for serum CK assays were taken from anesthetized rats just before the i.m. application of LA, at 1 and 3 hours afterwards and, in the preliminary experiment, also at 6 and 24 hours. A glass capillary, 2 mm outer diameter, was introduced through the internal canthus and pushed retrobulbarly to open the ophthalmic veins, and about 10 drops of blood were allowed to drip into a dry test-tube. The samples were centrifuged (5,000 r.p.m. for 15 Finutes) and 50 pl of the serum was mixed with 1.5 ml reaction mixture of a Behring Proper-zym@-CK set. After incubation (5 minutes, 25"C), CKactivity was determined by means ofultra-violet photometry in units (U)/liter. Because of the differences in CK values found in different animals, the rise in CK following LA application was expressed as a percentage of each animal's initial activity. For the statistical evaluation of changes in CK activity and for the assessment of other values, the differences between the mean readings were compared with the Student's t-test at 0.05 significance level.
Miiscle Rernoval and ?Veight Determination
The TA muscles were extirpated at 7 intervals: at days 1, 3, 4.5 (4 and 5), 7, 10.5 (10 or ll), 21, 33, and some at 55 days after LA injection. For each sampling period, the muscles were taken from 4 to 9 animals. The skin, fascia, and retinaculum extensorum were opened; the tendon of the TA muscle was transected; and the muscle belly was gently lifted proximally and cut off from the tibia1 periosteum. The tendon was cut down to 1 mm in length, and the wet weight of the muscle was determined. The contralateral control muscle was also weighed, and the weight of the LA-injected muscle was expressed as a percentage of the weight of the control muscle. In a preliminary experiment, no significant difference was found between the weights of the intact muscles from either side-0.3 +_ 0.7% (2 +-SEM, n = 14).
Microscopic Examination
The middle third of the muscle belly was crosssectioned into blocks 3 mm thick. Part of the blocks were fixed in 10% neutral formalin, dehydrated, and embedded in Paraplast. Cross-sections of the muscle TOXICOLOGIC PATHOLOGY (10 pm) were stained with hematoxylin and eosin (H&E). Other blocks were frozen in freon chilled with liquid nitrogen, cut in a cryostat, stained with H&E or used for histochemical enzyme reactions. These were alkaline phosphatase (naphthol AS-MX as substrate), acid phosphatase (naphthol AS-BI phosphate as substrate), and NADH, tetrazolium reductase (methods according to Lojda et a1 (28) ). Yet, other blocks were fixed with 2.5% glutaraldehyde and 1% OsO, in 0.1 M phosphate buffer, and embedded in Epon 812. Semi-thin sections were stained with toluidine blue. For the test proper, however, estimation of H&E-stained sections is sufficient.
Detertnination of the Extent of the Lesion
H&E-stained cross-sections from muscles examined 3 days after the application of LA and 1 day after the application of saline solution were pro-jected_ onto a paper with a 13 to 17 times enlargement. The boundaries of the damaged and intact areas were marked out. Both parts were then cut out and weighed, and the size of the lesion was expressed as a percent of the total cross-sectional area. Cases where the LA had been injected into the marginal portion of the muscle were excluded. In the preliminary experiment, a determination was made of the area of the muscle cross-section stained immediately after the i.m. application of 0.1 ml 1% Evans blue or 10% India ink. Injection of 0.1 ml of either of these substances resulted in the staining of 47 k 3% of the area of the muscle cross section (X f SEM, n = 7). LA are assumed to infiltrate an area as large as that stained by the dyes.
RESULTS
Seriun Creatine Kinase (CK)
The i.m. application of LA invariably resulted in an increase in serum CK, an elevation statistically significantly higher than after the i.m. application of saline solution (Table 11 ). In most cases, serum CK activity was the highest at 1 hour after the injection, except after 2% lidocaine and 2% mesocaine where the maximum was reached at 3 hours. At 6 and 24 hours, the serum CK level was regularly lower, often showing no statistically significant difference from the starting value. Table I1 describes the serum CK elevation induced by the intramuscular application of the local anesthetics. As the figures suggest, an increase of serum CK activity in the rat is a highly sensitive indicator of muscle damage. The increase in CK activity was closely correlated with the extent of muscle damage. A 6-fold or greater increase in seru'm CK signified major muscle damage. 
Macroscopic Findings
One day after the i.m. application of LA the muscles were mostly edematous, some with hemorrhage. Three days after injection of either 0.2% carbisocaine and 1% procaine, there were no noticeable changes on the muscle surface or in the freshly sectioned muscle. Three days after injection of the other LA one could see a pallid necrotic focus, sometimes with a hemorrhagic border. Toward the end of the first week, the lesions were not discernible except in muscles injected with 2% lidocaine or 2% mesocaine.
Mtiscle Weight
One day after the i.m. injection of LA, the muscles began to increase in weight, mainly because of edema. For the next few days, the muscle weight decreased, before increasing again through regeneration. The i.m. administration of each of the LA caused different patterns of the changes correspond-ing to the size and type of the lesion (Table 111 ). The i.m. application of 0.2% carbisocaine and 1% procaine resulted in only minor weight changes over a short period. After 0.5% marcaine, the muscle weight gain and loss were more pronounced, though by the middle of the second week of the experiment the muscle weight had been restored. In contrast, the application of 2% mesocaine and 2% lidocaine caused a very conspicuous initial gain and subsequent loss of the muscle weight, and restoration of weight did not approach completion until after 3 weeks. Table IV gives a list of LA in the order of the size of the lesion produced by their i.m. application. Most of the LA damaged the muscle over an area smaller than the expected region of infiltration, which was 47 f 3% of the cross-section surface. Two percent lidocaine and 2% mesocaine alone caused damage over a roughly 10% larger area than the infil- tration area. Saline solution resulted in only negligible lesions (Fig. 1) . Given the same type of LA, the size of the lesions grew as the concentration of the solution increased 2% mesocaine caused lesions nearly twice as large as 1% mesocaine, and lesions resulting from 2% procaine and 2% lidocaine were nearly 4 times as large as lesions resulting from injections of 1% solutions.
Size of Lesion
Microscopic Findings
LA caused 2 types of focal lesions. One was characterized by an almost selective damage to and necrosis of muscle fibers. The other cells in the muscle suffered either no damage at all or solely in a small central portion of the lesion (Fig. 2) . This type of damage was induced by 0.2% carbisocaine, 1% lidocaine, 1% procaine and, to a larger extent, by 0.5% marcaine. In the periphery of this type of lesion only small-diameter muscle fibers ("red") had suffered irreversible damage whereas large-diameter fibers ("white") remained preserved (Fig. 2) .
The other type of lesion displayed a combination of selective myotoxic and generalized damage to the muscle (Fig. 3) . In the periphery of the lesion, only the muscle fibers were damaged or destroyed, whereas there was generalized necrosis of all cell types in the central area of the lesion. This type of lesion was caused by 2% lidocaine, 2% mesocaine and, to a smaller degree, also 1% mesocaine and 2% procaine. Muscle fiber damage toward the periphery of the area of injection was more uniform than in the former, more diffuse type of lesion.
Subsequent development depended upon the extent ofdamage. After selective damage to the muscle fibers, their satellite cells survived and began to divide before the necrotic fibers were completely phagocytized ( Fig. 4A ). Phagocytosis of necrotic muscle fibers and regeneration was rapid and occurred simultaneously throughout the lesion (Figs.  1, 4A, B ). From the third to the tenth day postinjection, the muscle fibers had regenerated (Fig.  4D ). Unlike this pattern, lesions characterized by generalized cytotoxicity were followed by a slow process of revascularization and phagocytosis of necrotic muscle fibers. Resolution of these lesions followed a pronounced centripetal gradient (Fig. 3 ) similar to that in a free muscle graft (1 2). Along the outer border of the lesion, phagocytosis and regeneration followed a course similar to that in the purely myotoxic lesions. In the paracentral region, however, phagocytosis and regeneration began later, and the appearance of myotubes was delayed (Fig. 4C ). In the central part, necrotic muscle'fibers persisted until the middle of the second week, with regeneration starting only after their removal by macrophages in the presence of already established con- at SAGE PUBLICATIONS on December 9, 2012 tpx.sagepub.com Downloaded from nective tissue (Fig. 4E) . Nevertheless, the destroyed muscle tissue had regenerated by the end ofthe thir$ week. At the same time, the muscle had been restructured. This became manifest later in the grouping together of muscle fibers of the same hztochemical type (Fig. 4F9 .
DISCUSSION
As follows from our description of the changes induced in the rat muscle by LA of different myotoxicity, a test for the intramuscular toxicity ofdrugs must include: 1) a definition of the types of cells damaged; 2) the extent of the lesion; and 3) the rate of subsequent muscle regeneration. For that reason, we believe that the following criteria should be established for tests conducted on rats: a) serum CK activity at 1 hour; b) macro-and microscopic findings in the muscle at 3, 7, and 21 days; c) size of the lesion at 3 days; and d) muscle weight 7 and 2 1 days after the i.m. injection of the test substance.
Serum Creatine Kinase (CK) Activity
The rapid rise in serum CK activity is an acute indicator of drug myotoxicity (43) . Following the i.m. application of LA, CK in the serum of the rat increased rapidly and prominently even in the minor muscle lesions. One percent procaine, which is regarded as a low-toxicity LA (15) , and which in our own experiments, too, induced but small lesions, was responsible for a 4.5-fold increase in serum CK. In contrast, 2% lidocaine and 2% mesocaine, which we found to be highly myotoxic agents, produced 8-to 16-fold increases in serum CK. Certain antiphlogistic agents result in severe muscle lesions, which are characterized by a permanent loss of muscle fibers and the deposition of connective tissue in the injected region of the muscle. Two such agents, 0.1 ml Tomanols (Byk-Gulden, Constance, FRG) or VoltarenB (Ciba-Geigy, Basel), injected into the tibialis anterior muscle of the rat, caused serum CK to rise to 10 to 17 times the initial value in 1 hour (21, 38) .
Judging by parallel morphological findings, an increase in the serum CK of the rat must be 5to 6-fold in order to be regarded as an indicator of major muscle damage. Changes in serum CK, however, are not sufficient as an indicator of muscle damage because they do not aid in evaluating local damage to non-muscle cells, the participation of which is important in the repair ofthe muscle lesion.
In the muscle fiber, CK is localized in the mitochondria, the sarcoplasmic reticulum, the free sarcoplasm (2), and also in the M-line of myofibrils (49) . Only part of the CK is released from the damaged muscle fibers into the serum. Since in the TA muscle of the rat, 97% of the total volume of CK is made up of the MM isoenzyme (36) , it is sufficient to assay the total serum CK activity, provided there is no simultaneous damage to the myocardium (isoenzyme MB) or to the brain (isoenzyme BB). After a study comparing 4 different methods of removing blood for CK assays, Friedel et a1 (16) concluded that use of a cannula introduced into the jugular vein provided data with the lowest values and the least amount of scatter. However, for repeated assays on the same animal over a period of up to 24 hours it was preferable to withdraw the blood with a glass capillary tube from the retrobulbar veins.
Occasional mechanical damage to the oculomotor muscles can cause extremely high CK values, and I then it is necessary to exclude the animal from the experimental series. In most cases, the level of serum CK activity corresponded to the extent of the lesion in the muscle. Only in the case of an i.m. injection of 2% procaine did the levels of serum CK activity exceed the apparent histological extent of the lesion, which was very small. The apparent discrepancy could be explained by the presence of reversible, anestheticinduced damage to the muscle fibers. Similarly, Baba et a1 (2) report that the serum CK increase in myocardial lesions corresponds to acute, even reversible, muscle cell damage rather than to the extent of necrosis detectable later on.
Serum CK activity can be rapidly assayed in clinical practice and compared with animal data. This strategy, in contrast to that of measuring CK levels directly from the regions of muscle damage (14,45), permits the use of the muscle for simultaneous morphological examination.
Morphological Findings
The macroscopic findings alone suggested the degree of muscle damage. After extensive, generalized damage, the lesion was readily detectable as long as 7 days after the substance was injected. However, microscopic examination is necessary to distinguish selective myotoxic damage from generalized tissue destruction. The optimum strategy is to use microscopy 3 days after LA application, by which time the lesion is already well defined and its size can be readily determined.
Determination of the size of the lesion provides a rough measure of the overall myotoxicity of the injected drug. Low toxicity of the LA is indicated by a lesion that is smaller than the area that was originally infiltrated by the drug. Toward the periphery of the lesion, one encounters a region where thin ("red") muscle fibers are more susceptible to the local concentration of LA than the larger "white" fibers. This region is characterized by the selective destruction of the small-diameter muscle fibers and TOXICOLOGIC PATHOLOGY survival of the larger ones. This differential sensitivity of muscle fiber types of the myotoxic effects of LA has already been noted by Benoit and Belt (6). This may be related to differences in the distribution of calcium ions in different types of muscle fibers, as described by Borges et a1 (8).
In contrast-to the picture noted above, the injection of highly toxic LA resulted in lesions that were larger than the expected area of original infiltration of the drug. These lesions, which were more clearly demarcated than those resulting from the injection of purely myotoxic LA, were characterized by generalized tissue destruction in the center and damage confined to the muscle fibers at the periphery. The central regions had the appearance and properties of foci of ischemic necrosis, whether primarily or secondarily produced. In such areas, both the capillary circulation is lacking and viable satellite cells are not present (35) . There are at least 2 possible explanations for the central focus of generalized tissue damage. One is damage secondary to prolonged ischemia, and the other is a direct cytotoxic effect of the anesthetics on a variety of cell types. Certain of the LA, such as 2% lidocaine and 2% mesocaine, are associated with vasoconstrictive effects (2 l), and this effect is more pronounced when vasoconstrictive substances are mixed with the anesthetics (1 5, 22) .
Another possible explanation for such generalized lesions is a direct toxicity of the LA on a variety of cell types in the center of the area of infiltration. If this destroys the capillary endothelial cells, as well, secondary ischemia could result. Studies conducted in vitro by Schultz and Lipton (4 1) and Hall-Craggs (23) have shown direct toxic effects by LA on fibroblasts and endothelial cells.
The determination of muscle weight and microscopic examination at 7 and 21 days after the application of the test substance allows one to estimate the progress of regeneration. Following selective myotoxic damage, muscle regeneration occurs almost synchronously throughout the lesion, and by 7 days it already contributes to the restoration of muscle weight. In generalized lesions damage to the satellite cells of the central muscle fibers and to the capillary endothelial cells worsened the conditions for a favorable course of regeneration. At 7 days in our experiments, muscle fiber regeneration was only seen at the periphery of such lesions. At that time, the muscle weight was at its lowest and it was not restored until the end of the third week. Nevertheless, even the greatest loss of weight (1 7%, i.e., about 60 mg of muscle mass) was eventually restored. In contrast, following the application of antiphlogistics the initial muscle weight was not restored even by the end of the fourth week, and'part of the muscle was replaced by connective tissue (38) . There was permanent muscle damage similar to that caused by repeated LA application in a single site in the rat (3, 50) or by repeated injections of chlorpromazine in man (1 0).
The Validity of the Test for Predictions of Intrainiisciilar Drug Toxicity in Hiiinans
As a number of serum CK assays suggest, LA as well as other drugs damage not only the muscles of experimental animals but also those of man (30,43, 5 1). Within 6 hours of the i.m. injection of 5 ml of 2% mesocaine, serum CK in man had risen to 3 13 +-134% (n = 11) of the initial value, and after TomanolB (3 ml) to 578 +. 186% (n = 12) of the initial value (Cepelikovii and Grim, unpublished) . At 30 minutes after infiltration of the tongue with mesocaine D, the destruction of muscle fibers in man was similar to that in the rat (22) . The human sternqcleidomastoid muscle, infiltrated 18 hours prior to surgery, with 2% lidocaine + epinephrine exhibited lesions similar to those seen in the rat muscle, except that the focus of damage in the human muscle was less well defined (50) . Similarly, after an injection of 2% lidocaine or 2% mesocaine, damaged necrotic fibers in the muscle ofthe monkey (Macaca mulatta) and the dog are more scattered than in rat muscle (Grim, unpublished) . According to Diness (1 4), inter-species differences could be ascribed to differences in 1) the distribution of the substance injected into the muscle; 2) the rate of its diffusion or absorption; or 3) the differential susceptibility of the muscle fibers of different species.
These differences could also be due to different distributions of the muscle fiber types, where "red" fibers are more susceptible to the myotoxic effect of LA than "white" ones. One cannot rule out interspecies differences in the arrangement of the endomysium and its possible effect on the diffusion of the substance injected. Any of these explanations could account for the more diffuse distribution of severely damaged muscle fibers in the human as compared to the rat.
The diffuseness of the LA-induced muscle fiber damage in the human should be favorable for muscle fiber regeneration which, however, takes a longer course in man than in the rat. As follows from investigations of human muscle regenerating after a defined onset of muscle damage (1, 39) and from studies of the regeneration of human muscle transplanted to an athymic nude mouse (48) , human muscle takes several times longer to regenerate than does rat muscle. As the above data suggest, the proposed test permits a reliable determination and mutual comparison of the intramuscular toxicity of drugs. For pre-dictions of this toxicity and its consequences, however, the effect of inter-species differences must be taken into account. We believe that in the development of new pharmaceuticals the test could be useful for selecting the most suitable drug out of a group of substances with a similar effect, and for choosing the most appropriate camer substances. For instance, aqueous solutions of neuroleptics exhibit more local toxicity than the same substances suspended in oil vehicles (46) . The i.m. application of vegetable oil vehicles resulted in only minimal damage to skeletal muscle (44; Grim and Reiibkovi, unpublished), whereas the application of propyleneglycol, a potential carrier substance, caused more damage to the muscle alone than did most LA (2 1)-
The initial determination of the local myotoxicity of a new drug should be a comprehensive process, using all of the criteria mentioned above. However, for the screening of minor derivatives of the drug in question it should be sufficient to use only some of the more sensitive tests. A substance can be considered to have a low level of myotoxicity if it meets the following criteria: 1) it triggers off a less than 5-fold increase in serum CK; 2) it induces lesions in only a small part of the infiltrated area; 3) it causes minimal damage to the capillary bed; and 4) it causes minimal changes in the weight of the muscle after injection. For substances that fail to meet these conditions, the importance of their therapeutic effect should be considered in relation to the severity of local muscle damage caused by the injection. Users should be warned ofthe local toxic effects on muscle, and the possibility of permanent muscle damage after repeated injections should be kept in mind.
